1 not yet recruiting, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma: new trials by email Literature Review of Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma trials Research Report on Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma Azacitidine, Belinostat, Biospecimen Collection - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 40 | 2027-01-03 | 2026-07-09 |
| Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma Brentuximab Vedotin, Pembrolizumab - Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma | Phase 2 | Withdrawn | Northwestern University | 2020-03-01 | 2023-10-10 |
Enteropathy-Associated T-Cell Lymphoma (2) · Lymphoma, T-Cell (2) · Subcutaneous panniculitis-like T-cell lymphoma (2) · Immunoblastic Lymphadenopathy (1) · Lymphoma, Large-Cell, Anaplastic (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphadenopathy (1)
10-propargyl-10-deazaaminopterin (1) · Azacitidine (1) · Brentuximab Vedotin (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · belinostat (1) · pembrolizumab (1)
City of Hope Medical Center (1) · Northwestern University (1)
United States (2)
Christina Poh (1) · Jonathan Moreira, MD (1)
P30CA033572 (1), P30CA060553 (1)